Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Warwick Hamer Insider Profile
4 Followers
Andrew Warwick Hamer, Chief Medical Officer at Cardiol Therapeutics, holds 447.71K shares in Cardiol Therapeutics (Ticker: CRDL).
Andrew Warwick Hamer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Warwick Hamer's holdings
Insider Roles
Chief Medical Officer
Roles that Andrew Warwick Hamer holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew Warwick Hamer
Andrew Warwick Hamer's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Warwick Hamer's performance on stock
You May Also Like
Andrew Warwick Hamer insider profile FAQ
What is the percentage of profitable transactions made by Andrew Warwick Hamer?
The percentage of profitable transactions made by Andrew Warwick Hamer is ―.
What is the average return per transaction made by Andrew Warwick Hamer?
The average return per transaction made by Andrew Warwick Hamer is ―.
What stocks does Andrew Warwick Hamer hold?
Andrew Warwick Hamer holds: CRDL stocks.
What was Andrew Warwick Hamer’s latest transaction?
Andrew Warwick Hamer latest transaction was an Uninformative Sell of ―.
What was Andrew Warwick Hamer's most profitable transaction?
Andrew Warwick Hamer’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew Warwick Hamer's role in Cardiol Therapeutics?
Andrew Warwick Hamer's role in Cardiol Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.